Skip to main content
Signal8
Launch Terminal

Fresenius SE & Co. KGaA (FSNUY)

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Care Facilities

Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA

OTC:FSNUYHealthcare
Mkt Cap-
Float1.64B
O/S-
Inst Own-
SI<0.1%
Div Yield2.36%
Dilution
Fresenius SE & Co. KGaA logoOTC:FSNUY
FormDescription
13D/A
Beneficial Ownership Report (Active, Amended)
13D/A
Beneficial Ownership Report (Active, Amended)
13D/A
Beneficial Ownership Report (Active, Amended)
13D/A
Beneficial Ownership Report (Active, Amended)
13D/A
Beneficial Ownership Report (Active, Amended)
13D/A
Beneficial Ownership Report (Active, Amended)
3
Initial Statement of Beneficial Ownership
13D
Beneficial Ownership Report (Active)
F-6 POS
SEC Filing
13D/A
AMENDMENT NO. 7
13D/A
SCHEDULE 13D/A 6
13D/A
AMENDMENT NO. 5
EFFECT
F-6,,2011-10-26 09:00:00
F-6
SEC Filing
13D/A
SCHEDULE 13D/A
13D/A
SCHEDULE 13D/A
13D/A
Beneficial Ownership Report (Active, Amended)
NO ACT
AUTO-GENERATED PAPER DOCUMENT
13D/A
AMENDMENT NO. 1 TO SCHEDULE 13D
13D/A
SCHEDULE 13D/A
13D/A
AMENDMENT #7 TO SCHEDULE 13D
13D/A
AMENDMENT #6 TO SCHEDULE 13D
13D/A
AMENDED SC 13D
13D/A
AMENDMENT TO SCHEDULE 13D
13D/A
SCHEDULE 13D/A AMENDMENT #3

1-25 of 29